Orchestrating mast cell for cancer immunotherapy
International Immunopharmacology · 2026-07 · 181 · 116761
DOI: 10.1016/j.intimp.2026.116761 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026-07. Verfasst von Shu-Jin Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Mast Cells, Neoplasms, Immunotherapy. Die Arbeit nennt 164 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer immunotherapy has revolutionized oncology by harnessing the immune system to combat malignant tumors, driving significant advancements in cancer treatment. However, due to the complex interplay between tumor cells and immune cells, many patients fail to achieve durable responses. Mast cells are bone marrow-derived immune cells and a crucial component of the innate immune system. Previously, mast cells were primarily recognized for their roles in allergic and inflammatory responses. In recent years, increasing attention has been directed toward their dual functions in the tumor microenvironment during cancer progression, highlighting the potential of mast cell-targeted strategies in cancer immunotherapy. This review summarized recent advances about the dual role of mast cells in the tumor microenvironment. At the same time, this review further evaluates the translational potential of mast cells as predictive markers and innovative therapeutic targets for cancer immunotherapy. By elucidating these mechanisms, this review aims to bridge the gap between preclinical insights and clinical applications, offering a roadmap for mast cell-centric approaches to overcome resistance and improve outcomes in cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Sci…
- Department of Stomatology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China. Electronic address: yangfuhua2012@whu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, S. J., Lv, S. J., Yang, F. H., & Sun, Z. J. (2026). Orchestrating mast cell for cancer immunotherapy. International Immunopharmacology, 181, 116761. https://doi.org/10.1016/j.intimp.2026.116761
Vancouver
Li SJ, Lv SJ, Yang FH, Sun ZJ. Orchestrating mast cell for cancer immunotherapy. International Immunopharmacology. 2026;181:116761. doi:10.1016/j.intimp.2026.116761
BibTeX
@article{Li2026,
author = {Li, Shu-Jin and Lv, Shi-Jie and Yang, Fu-Hua and Sun, Zhi-Jun},
title = {Orchestrating mast cell for cancer immunotherapy},
journal = {International Immunopharmacology},
year = {2026},
volume = {181},
pages = {116761},
doi = {10.1016/j.intimp.2026.116761}
}
EUVIMED